Skip to content

Clinical Research on Bowel Symptoms of Patient With Pelvic Organ Prolapse

Clinical Research on Bowel Symptoms of Patients With Pelvic Organ Prolapse

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02731391
Enrollment
200
Registered
2016-04-07
Start date
2016-04-30
Completion date
2022-05-31
Last updated
2021-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel Symptoms

Brief summary

To study the prevalence of bowel symptoms in patients with pelvic organ prolapse.

Interventions

PROCEDUREPelvic floor reconstruction(with or without mesh)

Sponsors

Peking University People's Hospital
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patients with stage\>2 POP are recruited.The patients are all received surgeries, which include transvaginal synthetic mesh surgery, the sacral fixation, tissue repair surgery and colpocleisis.

Exclusion criteria

* Gestation; * Inflammatory bowel disease; * Slow transit constipation diagnosed by Colonic transit test; * Unable to follow up.

Design outcomes

Primary

MeasureTime frameDescription
change in the prevalence of bowel symptomsbaseline,1,3,6,12 months after operation.
change in the severity of intestinal symptomsbaseline,1,3,6,12 months after operation.assessed by Birmingham Bowel and Urinary Symptoms Questionnaire

Secondary

MeasureTime frameDescription
change in the quality of lifebaseline,1,3,6,12 months after operation.assessed by international consultation on incontinence questionnaire short form
length of the high-pressure zone recorded by anorectal manometrybaseline and 12 months after operation
rectoanal inhibitory reflex recorded by anorectal manometrybaseline and 12 months after operation
Rectal-Vaginal pressure interval during maximum Vasalvabaseline and 6 months after operationMeasured by Peritron manometer

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026